Unknown

Dataset Information

0

Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?

ABSTRACT:

SUBMITTER: Kacar M 

PROVIDER: S-EPMC8311417 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
| S-EPMC4880074 | biostudies-literature
Unknown Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.
| S-EPMC8727472 | biostudies-literature
Unknown Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19.
| S-EPMC8923117 | biostudies-literature
Unknown Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19.
| S-EPMC9243824 | biostudies-literature
Unknown Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
| S-EPMC6702949 | biostudies-literature
Unknown Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients.
| S-EPMC8689695 | biostudies-literature
Unknown Neutralizing Anti-Cytokine Autoantibodies Against Interferon-? in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked.
| S-EPMC5885158 | biostudies-literature
Unknown Cohort survey of healthcare workers with COVID-19 infection
| S-BSST563 | biostudies-other
Unknown Interferon gamma runs interference on persistent COVID-19
| S-EPMC8500527 | biostudies-literature
Unknown Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies.
| S-EPMC8141761 | biostudies-literature